Concepedia

Pamela Wedel

PW

Statistics

Publications

10

Citations

437

H-Index

10

Active since

2012

Affiliations

Amplyx Pharmaceuticals (United States)(Current)

Pfizer (United States)

Augusta University

University of Alabama at Birmingham

CHU Dinant Godinne UCL Namur

Pamela Wedel is an author at Amplyx Pharmaceuticals (United States) specializing in medicine, pharmacology, and depression.

Top concepts

Publications per year

2012–2023

10

Publications

10

Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris <i>:</i> Results from a Phase 2 Trial

José A. Vázquez, Peter G. Pappas, Kenneth D Boffard et al. · Antimicrobial Agents and Chemotherapy · 2023 · 65 citations · Full text

An exploratory study of combination buspirone and melatonin SR in Major Depressive Disorder (MDD): A possible role for neurogenesis in drug discovery

Maurizio Fava, Steven D. Targum, Andrew A. Nierenberg et al. · Journal of Psychiatric Research · 2012 · 64 citations

, , +11

Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse

S H Kim, John Steele, Seohyeon Lee et al. · Molecular Psychiatry · 2014 · 57 citations · Full text

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial

Peter G. Pappas, José A. Vázquez, Ilana Oren et al. · Journal of Antimicrobial Chemotherapy · 2023 · 50 citations · Full text

Phase 1 Study to Assess Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of APX001 and to Investigate the Effect of Food on APX001 Bioavailability

Michael R. Hodges, Eric Ople, Karen Joy Shaw et al. · Open Forum Infectious Diseases · 2017 · 47 citations · Full text

, , +20

1–5 of 10